Innate Pharma SA Other Adjustments To Reconcile Profit Loss
Innate Pharma SA (IPHYF) reported Other Adjustments To Reconcile Profit Loss of -EUR 2.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OtherAdjustmentsToReconcileProfitLoss · last filed 2026-04-01
| Period end | Other Adjustments To Reconcile Profit Loss 6 month | Other Adjustments To Reconcile Profit Loss 12 month |
|---|---|---|
| 2025-12-31 | -2.00K EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 3.00K EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 24.00K EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 26.00K EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 6.00K EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 6.00K EUR 6-K · filed 2023-09-14 | |
| 2022-12-31 | 15.00K EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | -52.00K EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | -1.19M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | -1.48M EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | -254.00K EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | -373.00K EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 550.00K EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-04-27 |